(Q44208681)

English

Severe acute nephrotoxicity in a kidney transplant patient despite low tacrolimus levels: a possible interaction between donor and recipient genetic polymorphisms

scientific article published on 9 April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Severe acute nephrotoxicity in a kidney transplant patient despite low tacrolimus levels: a possible interaction between donor and recipient genetic polymorphisms (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Armando A. Genazzani

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

M Quaglia

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

S Terrazzino

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

R Boldorini

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

P Stratta

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

9 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Journal of Clinical Pharmacy and Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

333-336

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

CYP3A5 genotype-phenotype analysis in the human kidney reveals a strong site-specific expression of CYP3A5 in the proximal tubule in carriers of the CYP3A5*1 allele.

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

Lower tacrolimus daily dose requirements and acute rejection rates in the CYP3A5 nonexpressers than expressers

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

Outcome of kidney transplantation from high-risk donors is determined by both structure and function

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

The use of therapeutic drug monitoring to optimise immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

BK virus sequences in specimens from aborted fetuses

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population.

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

Tacrolimus dose requirements and CYP3A5 genotype and the development of calcineurin inhibitor-associated nephrotoxicity in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

Lowered blood concentration of tacrolimus and its recovery with changes in expression of CYP3A and P-glycoprotein after high-dose steroid therapy

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

Calcineurin inhibitor-induced nephrotoxicity and renal expression of P-glycoprotein

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

The effect of CYP3A5 6986A>G and ABCB1 3435C>T on tacrolimus dose-adjusted trough levels and acute rejection rates in renal transplant patients: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

Effect of a new functionalCYP3A4polymorphism on calcineurin inhibitors’ dose requirements and trough blood levels in stable renal transplant patients

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12066

21 January 2018

Identifiers

10.1111/JCPT.12066

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44208681&oldid=2108553305"